Report Detail

Request for Sample of this report

Global Canine Stem Cell Therapy Market Segment Analysis, Opportunity Assessment, Competitive Intelligence, Industry Outlook 2016-2026

RnM3897741
25 February, 2020
Global
135 Pages
AllTheResearch
Healthcare

The global canine stem cell therapy market was valued USD 118.5 Million in 2018 and is likely to reach USD 240.7 Million by 2026, with a compound annual growth rate of xx% over the forecast period 2019-2026. Canine stem cell therapy is a disease-modifying therapy used for the treatment of degenerative disorders such as arthritis of hips, elbows, shoulders, etc. Factors like rising prevalence of canine arthritis and increasing investment in research and development are expected to accentuate the growth of the canine stem cell therapy market. However, stem cell therapy is an expensive procedure as compared to other treatment options and this is impeding the growth of the market. Moreover, the lack of pet insurance will further restrain the growth of the market. The Autologous Stem Cells segment is expected to dominate the market throughout the forecast periodBased on type, the global canine stem cell therapy market has been segmented into autologous stem cells and allogeneic stem cells. The autologous stem cells segment accounts for more than 80% of the global canine stem cell therapy market. This segment is expected to reach $xx million by 2026 from $xx in 2019, growing at a significant rate.The major factor that is driving the growth of this segment is the approval of autologous stem cell therapy for indications such as spinal injuries, gastrointestinal issues, bone repair, and renal conditions. However, the expensive nature of the therapy as compared to allogeneic stem cell therapy and the longer time required for sample acquiring, processing, and the final treatment may impede the growth of this segment.The allogeneic stem cell therapy segment is also growing at a significant rate. This segment has been driven by factors such as faster treatment availability, better efficacy rate, non-invasiveness of the therapy for patient animals, and cost benefits, as compared to the autologous stem cell therapy.Based on application, the treatment segment is expected to dominant the market during the forecast periodBased on applications, the market has been segmented into treatment and research. The treatment segment accounts for the largest share in the global canine stem cell therapy market by application. The rising prevalence of canine arthritis is driving the growth of this market segment. The increasing penetration of pet insurance and growing awareness about stem cell therapy will lead to the rising adoption of stem cell therapy and thereby, drive the treatment segment of the market.Based on the end-user, the veterinary clinics segment is expected to dominate during the forecast periodBased on the end-user, the market has been segmented into veterinary hospitals, veterinary clinics, and veterinary research institutes. The veterinary clinics segment accounts for the largest share in the market and held more than 60% of the total market in 2018. The increasing number of veterinary clinics offering stem cell therapy will drive the growth of this end-user segment. Furthermore, there has been an expansion in the number of veterinary clinic chains, which has made treatment more accessible over a wide geography. This will also drive the growth of the veterinary clinics end-user segment.North America to dominate the global canine stem cell therapy market throughout the forecast periodNorth America accounted for the highest share in 2018 and is expected to continue its dominance in the market throughout the forecast period. North America has the highest population of pet dogs, with around 73 million dogs in the US and over 6 million in Canada. The rising pet ownership in this region is one of the most important factors driving the growth of this market. The US accounted for around 90% of the market in 2018. The rising research and development activity in this region will also augment the growth of the canine stem cell therapy market.Company Profiles and Competitive Intelligence:The major players operating in this market are VetStem Biopharma, Medrego, and Magellan Stem Cells, amongst others. Most of the companies are conducting clinical trials to study the safety and efficacy of stem cells for various indication such as spinal disorders, renal disorders, etc.

Chapter 1 Preface

1.1 Report Description
- 1.1.1 Purpose of the Report
- 1.1.2 Target Audience
- 1.1.3 USP and Key Offerings
1.2 Research Scope
1.3 Research Methodology
- 1.3.1 Phase I – Secondary Research
- 1.3.2 Phase II – Primary Research
- 1.3.3 Phase III – Expert Panel Review
- 1.3.4 Approach Adopted
  - 1.3.4.1 Top-Down Approach
  - 1.3.4.2 Bottom-Up Approach
- 1.3.5 Assumptions
1.4 Market Segmentation Scope

Chapter 2 Executive Summary

2.1 Market Summary
- 2.1.1 Global Canine Stem Cell Therapy Market, 2016-2026, (US$ Mn)
2.1 Market Snapshot: Global Canine Stem Cell Therapy Market
2.2 Market Dynamics
2.3 Global Canine Stem Cell Therapy Market, by Segment, 2018
- 2.3.1 Global Canine Stem Cell Therapy Market, by Type, 2018, (US$ Mn)
- 2.3.2 Global Canine Stem Cell Therapy Market, by Application, 2018, (US$ Mn)
- 2.3.3 Global Canine Stem Cell Therapy Market, by End-user, 2018, (US$ Mn)
- 2.3.4 Global Canine Stem Cell Therapy Market, by Region, 2018 (US$ Mn)
2.4 Premium Insights
- 2.4.1 Canine Stem Cell Therapy Market In Developed Vs. Developing Economies, 2018 vs 2026
- 2.4.2 Global Canine Stem Cell Therapy Market: Regional Life Cycle Analysis
- 2.4.3 Industry Policies
- 2.4.4 Production Process and Manufacturing Cost Analysis

Chapter 3 Market Dynamics

3.1 Market Overview
3.2 Market Drivers
- 3.2.1 Increasing prevalence of chronic diseases
- 3.2.2 Increasing investment in R&D by market players and government bodies
3.3 Market Restraints
- 3.3.1 Expensive nature of the therapy
- 3.3.2 Restraint 2
3.4 Market Opportunities
- 3.4.1 Emerging applications of stem cell therapy
- 3.4.2 Opportunity 2
3.5 Industry Value Chain Analysis
- 3.5.1 Analyst’s Views
3.6 Industry SWOT Analysis
3.7 Industry Porter’s Five Forces Analysis

Chapter 4 Global Canine Stem Cell Therapy Market, by Type

4.1 Market Overview, by Type
- 4.1.1 Global Canine Stem Cell Therapy Market, by Type, 2016-2026 (US$ Mn)
- 4.1.2 Incremental Opportunity, by Type, From 2018-2026
4.2 Autologous Stem Cells
- 4.2.1 Global Canine Stem Cell Therapy Market, by Autologous Stem Cells, 2016-2026, (US$ Mn)
4.3 Allogeneic Stem Cells
- 4.3.1 Global Canine Stem Cell Therapy Market, by Allogeneic Stem Cells, 2016-2026, (US$ Mn)

Chapter 5 Global Canine Stem Cell Therapy Market, by Application

5.1 Market Overview, by Application
- 5.1.1 Global Canine Stem Cell Therapy Market, by Application, 2016-2026 (US$ Mn)
- 5.1.2 Incremental Opportunity, by Application, From 2018-2026
5.2 Treatment
- 5.2.1 Global Canine Stem Cell Therapy Market, by Treatment, 2016-2026, (US$ Mn)
5.3 Research
- 5.3.1 Global Canine Stem Cell Therapy Market, by Research, 2016-2026, (US$ Mn)

Chapter 6 Global Canine Stem Cell Therapy Market, by End-user

6.1 Market Overview, by End-user
- 6.1.1 Global Canine Stem Cell Therapy Market, by End-user, 2016-2026 (US$ Mn)
- 6.1.2 Incremental Opportunity, by End-user, From 2018-2026
6.2 Veterinary Hospitals
- 6.2.1 Global Canine Stem Cell Therapy Market, by Veterinary Hospitals, 2016-2026, (US$ Mn)
6.3 Veterinary Clinics
- 6.3.1 Global Canine Stem Cell Therapy Market, by Veterinary Clinics, 2016-2026, (US$ Mn)
6.4 Veterinary Research Institutes
- 6.4.1 Global Canine Stem Cell Therapy Market, by Veterinary Research Institutes, 2016-2026,

(US$ Mn)

Chapter 7 Global Canine Stem Cell Therapy Market, by Region

7.1 Market Overview, by Region
- 7.1.1 Global Canine Stem Cell Therapy Market, by Region, 2016-2026, (US$ Mn)
7.2 Attractive Investment Opportunity, by Region, 2018
7.3 North America Canine Stem Cell Therapy Market
- 7.3.1 North America Canine Stem Cell Therapy Market, by Type, 2016-2026 (US$ Mn)
- 7.3.2 North America Canine Stem Cell Therapy Market, by Application, 2016-2026 (US$ Mn)
- 7.3.3 North America Canine Stem Cell Therapy Market, by End-user, 2016-2026 (US$ Mn)
- 7.3.4 United States Country Profile
  - 7.3.4.1 United States Canine Stem Cell Therapy Market, 2016-2026 (US$ Mn)
- 7.3.5 Canada Country Profile
  - 7.3.5.1 Canada Canine Stem Cell Therapy Market, 2016-2026 (US$ Mn)
7.4 Europe Canine Stem Cell Therapy Market
- 7.4.1 Europe Canine Stem Cell Therapy Market, by Type, 2016-2026 (US$ Mn)
- 7.4.2 Europe Canine Stem Cell Therapy Market, by Application, 2016-2026 (US$ Mn)
- 7.4.3 Europe Canine Stem Cell Therapy Market, by End-user, 2016-2026 (US$ Mn)
- 7.4.4 United Kingdom Country Profile
  - 7.4.4.1 United Kingdom Canine Stem Cell Therapy Market, 2016-2026 (US$ Mn)
- 7.4.5 Germany Country Profile
  - 7.4.5.1 Germany Canine Stem Cell Therapy Market, 2016-2026 (US$ Mn)
- 7.4.6 France Country Profile
  - 7.4.6.1 France Canine Stem Cell Therapy Market, 2016-2026 (US$ Mn)
- 7.4.7 Spain Country Profile
  - 7.4.7.1 Spain Canine Stem Cell Therapy Market, 2016-2026 (US$ Mn)
- 7.4.8 Italy Country Profile
  - 7.4.8.1 Italy Canine Stem Cell Therapy Market, 2016-2026 (US$ Mn)
- 7.4.9 Rest of Europe
  - 7.4.9.1 Rest of Europe Canine Stem Cell Therapy Market, 2016-2026 (US$ Mn)
7.5 Asia Pacific Canine Stem Cell Therapy Market
- 7.5.1 Asia Pacific Canine Stem Cell Therapy Market, by Type, 2016-2026 (US$ Mn)
- 7.5.2 Asia Pacific Canine Stem Cell Therapy Market, by Application, 2016-2026 (US$ Mn)
- 7.5.3 Asia Pacific Canine Stem Cell Therapy Market, by End-user, 2016-2026 (US$ Mn)
- 7.5.4 China Country Profile
  - 7.5.4.1 China Canine Stem Cell Therapy Market, 2016-2026 (US$ Mn)
- 7.5.5 Japan Country Profile
  - 7.5.5.1 Japan Canine Stem Cell Therapy Market, 2016-2026 (US$ Mn)
- 7.5.6 India Country Profile
  - 7.5.6.1 India Canine Stem Cell Therapy Market, 2016-2026 (US$ Mn)
- 7.5.7 Rest of Asia Pacific
  - 7.5.7.1 Rest of Asia Pacific Canine Stem Cell Therapy Market, 2016-2026 (US$ Mn)
7.6 Latin America Canine Stem Cell Therapy Market
- 7.6.1 Latin America Canine Stem Cell Therapy Market, by Type, 2016-2026 (US$ Mn)
- 7.6.2 Latin America Canine Stem Cell Therapy Market, by Application, 2016-2026 (US$ Mn)
- 7.6.3 Latin America Canine Stem Cell Therapy Market, by End-user, 2016-2026 (US$ Mn)
- 7.6.4 Brazil Country Profile
  - 7.6.4.1 Brazil Canine Stem Cell Therapy Market, 2016-2026 (US$ Mn)
- 7.6.5 Mexico Country Profile
  - 7.6.5.1 Mexico Canine Stem Cell Therapy Market, 2016-2026 (US$ Mn)
- 7.6.6 Rest of Latin America
  - 7.6.6.1 Rest of Latin America Canine Stem Cell Therapy Market, 2016-2026 (US$ Mn)
7.7 Middle East & Africa Canine Stem Cell Therapy Market
- 7.7.1 Middle East & Africa Canine Stem Cell Therapy Market, by Type, 2016-2026 (US$ Mn)
- 7.7.2 Middle East & Africa Canine Stem Cell Therapy Market, by Application, 2016-2026 (US$ Mn)
- 7.7.3 Middle East & Africa Canine Stem Cell Therapy Market, by End-user, 2016-2026 (US$ Mn)
- 7.7.4 GCC Country Profile
  - 7.7.4.1 GCC Canine Stem Cell Therapy Market, 2016-2026 (US$ Mn)
- 7.7.5 Rest of Middle East & Africa
  - 7.7.5.1 Rest of Middle East & Africa Canine Stem Cell Therapy Market, 2016-2026 (US$ Mn)
Chapter 8 Competitive Intelligence
- 8.1 Introduction
- 8.2 Players Evaluated During the Study
- 8.3 Market Players Present in Market Life Cycle
- 8.4 Top 5 Players Comparison
- 8.5 Market Positioning of Key Players, 2018
- 8.6 Market Players Mapping
  - 8.6.1 By Type
  - 8.6.2 By Application
  - 8.6.3 By End-user
  - 8.6.4 By Region
- 8.7 Strategies Adopted by Key Market Players
- 8.8 Recent Developments in the Market
  - 8.8.1 Mergers & Acquisitions, Partnership, New Product Developments
- 8.9 Operational Efficiency Comparison by Key Players
Chapter 9 Company Profiles
- 9.1 VetStem Biopharma Inc.
  - 9.1.1 VetStem Biopharma Inc. Overview
  - 9.1.2 Key Stakeholders/Person in VetStem Biopharma Inc.
  - 9.1.3 VetStem Biopharma Inc. Products Portfolio
  - 9.1.4 VetStem Biopharma Inc. Financial Overview
  - 9.1.5 VetStem Biopharma Inc. News/Recent Developments
- 9.2 Cell Therapy Sciences
  - 9.2.1 Cell Therapy Sciences Overview
  - 9.2.2 Key Stakeholders/Person in Cell Therapy Sciences
  - 9.2.3 Cell Therapy Sciences Products Portfolio
  - 9.2.4 Cell Therapy Sciences Financial Overview
  - 9.2.5 Cell Therapy Sciences News/Recent Developments
- 9.3 Aratana Therapeutics, Inc.
  - 9.3.1 Aratana Therapeutics, Inc. Overview
  - 9.3.2 Key Stakeholders/Person in Aratana Therapeutics, Inc.
  - 9.3.3 Aratana Therapeutics, Inc. Products Portfolio
  - 9.3.4 Aratana Therapeutics, Inc. Financial Overview
  - 9.3.5 Aratana Therapeutics, Inc. News/Recent Developments
- 9.4 Regeneus Ltd
  - 9.4.1 Regeneus Ltd Overview
  - 9.4.2 Key Stakeholders/Person in Regeneus Ltd
  - 9.4.3 Regeneus Ltd Products Portfolio
  - 9.4.4 Regeneus Ltd Financial Overview
  - 9.4.5 Regeneus Ltd News/Recent Developments
- 9.5 Medivet Biologics LLC
  - 9.5.1 Medivet Biologics LLC Overview
  - 9.5.2 Key Stakeholders/Person in Medivet Biologics LLC
  - 9.5.3 Medivet Biologics LLC Products Portfolio
  - 9.5.4 Medivet Biologics LLC Financial Overview
  - 9.5.5 Medivet Biologics LLC News/Recent Developments
- 9.6 Vetbiologics
  - 9.6.1 Vetbiologics Overview
  - 9.6.2 Key Stakeholders/Person in Vetbiologics
  - 9.6.3 Vetbiologics Products Portfolio
  - 9.6.4 Vetbiologics Financial Overview
  - 9.6.5 Vetbiologics News/Recent Developments
- 9.7 Stemcellvet
  - 9.7.1 Stemcellvet Overview
  - 9.7.2 Key Stakeholders/Person in Stemcellvet
  - 9.7.3 Stemcellvet Products Portfolio
  - 9.7.4 Stemcellvet Financial Overview
  - 9.7.5 Stemcellvet News/Recent Developments
- 9.8 Magellan Stem Cells
  - 9.8.1 Magellan Stem Cells Overview
  - 9.8.2 Key Stakeholders/Person in Magellan Stem Cells
  - 9.8.3 Magellan Stem Cells Products Portfolio
  - 9.8.4 Magellan Stem Cells Financial Overview
  - 9.8.5 Magellan Stem Cells News/Recent Developments
- 9.9 Medrego
  - 9.9.1 Medrego Overview
  - 9.9.2 Key Stakeholders/Person in Medrego
  - 9.9.3 Medrego Products Portfolio
  - 9.9.4 Medrego Financial Overview

Medical Laser Market Report

Data Usage Trackers Market Report

Summary:
Get latest Market Research Reports on Canine Stem Cell Therapy. Industry analysis & Market Report on Canine Stem Cell Therapy is a syndicated market report, published as Global Canine Stem Cell Therapy Market Segment Analysis, Opportunity Assessment, Competitive Intelligence, Industry Outlook 2016-2026. It is complete Research Study and Industry Analysis of Canine Stem Cell Therapy market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

Last updated on 25 February, 2020

1-User License	$3,900.00
Enterprise License	$4,900.00

1-User License	3,112.20
Enterprise License	3,910.20

1-User License	3,638.70
Enterprise License	4,571.70

1-User License	599,664.00
Enterprise License	753,424.00

1-User License	325,494.00
Enterprise License	408,954.00

Report Detail

Request for Sample of this report

Request for Sample of this report

Global Canine Stem Cell Therapy Market Segment Analysis, Opportunity Assessment, Competitive Intelligence, Industry Outlook 2016-2026

Table Of Content

Chapter 1 Preface

Chapter 2 Executive Summary

Chapter 3 Market Dynamics

Chapter 4 Global Canine Stem Cell Therapy Market, by Type

Chapter 5 Global Canine Stem Cell Therapy Market, by Application

Chapter 6 Global Canine Stem Cell Therapy Market, by End-user

(US$ Mn)

Chapter 7 Global Canine Stem Cell Therapy Market, by Region

Chapter 8 Competitive Intelligence

Chapter 9 Company Profiles

REPORT YOU MIGHT BE INTERESTED

Purchase this Report

Related Reports

Reason to Buy

Trusted By Leaders

Shop With Confidence

Customer Centric

Personalized Solutions

Secure Checkout

Request for Sample of this report

Reports and Markets

Contact Us

Support

Newsletter